Convergence Investment Partners’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-3,975
Closed -$310K – 234
2021
Q3
$310K Buy
3,975
+44
+1% +$3.66K 0.17% 140
2021
Q2
$299K Sell
3,931
-382
-9% -$26.7K 0.13% 163
2021
Q1
$277K Buy
+4,313
New +$259K 0.13% 169
2018
Q3
– Sell
-32,689
Closed -$949K – 316
2018
Q2
$949K Buy
+32,689
New +$993K 0.13% 202
2017
Q1
– Sell
-95,333
Closed -$2.02M – 339
2016
Q4
$2.02M Buy
+95,333
New +$2.08M 0.28% 136
2016
Q2
– Sell
-19,138
Closed -$536K – 314
2016
Q1
$536K Sell
19,138
-23,920
-56% -$596K 0.06% 292
2015
Q4
$1.04M Buy
+43,058
New +$894K 0.12% 248

Other funds holding BRKR

Convergence Investment Partners's BRKR Position: Q4 2021 in Review

Convergence Investment Partners sold out of Bruker (BRKR) in Q4 2021, closing a stake of 3,975 shares — an estimated $310K sold.

Convergence Investment Partners first reported a position in BRKR in Q4 2015 and held it in 7 quarters. The position peaked at $2.02M in Q4 2016. 327 funds tracked by Wall St. Rank hold BRKR as of Q4 2021.

  • Convergence Investment Partners reported no remaining Bruker position as of Q4 2021 after selling out during the quarter.
  • Convergence Investment Partners sold 3,975 Bruker shares in Q4 2021, an estimated $310K.
  • Convergence Investment Partners first reported a position in Bruker in Q4 2015 and held it in 7 quarters.
  • Convergence Investment Partners's Bruker position peaked at $2.02M in Q4 2016.
  • 327 funds tracked by Wall St. Rank held Bruker as of Q4 2021.

Based on Convergence Investment Partners's 13F filing for Q4 2021, filed 25 Jan 2022.